Turret Capital
New York City, New Yorkturretfunds.com
Overview
Turret Capital is a global biomedical investment and venture-building company that focuses on early-stage investments. Headquartered in New York with a presence in Asia, the firm's mission is to elevate global healthcare standards through company creation, investments, and cross-border strategies, particularly between the US and Asia. It identifies as a venture builder and is also classified as an accelerator/incubator, with a focus on healthcare and medical technologies.
Portfolio Companies
4
Website
turretfunds.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sable Bio | Feb 2026 | Seed | Co-investor |
| Onego Bio | Apr 2024 | Series A | Co-investor |
| Egret Therapeutics | Feb 2022 | Seed | Co-investor |
| Milu Labs | Mar 2019 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.